Literature DB >> 25973029

ACE2-Ang (1-7) axis is induced in pressure overloaded rat model.

Bai Liang1, Yongqin Li2, Zhenhua Han2, Jiahong Xue2, Yan Zhang2, Shan Jia2, Congxia Wang2.   

Abstract

ACE2-Ang (1-7) axis is a key regulator in cardiac hypertrophy, myocardial remodeling and development of heart failure. To investigate how ACE2-Ang (1-7) axis function in pressure-overload-induced heart failure, male SD rats (weighing about 250 g) were used to establish the model of pressure-overload-induced heart failure using aortic stenosis surgery. The level of plasma ACE2, ACE and Ang (1-7) from heart failure group were significantly up-regulated compared with the sham group by ELISA test. The mRNA and protein expression of ACE2 in myocardial tissue from heart failure group also showed remarkably increased. Importantly, we found that the expression of ACE2 and Ang (1-7) were reversed in heart failure group after treatment with AT1 receptor antagonist telmisartan. Compared with heart failure group, the level of plasma ACE2, ACE and Ang (1-7) were significantly decreased in telmisartan treated group. The mRNA and protein expression of ACE2 in cardiac tissue from telmisartan group was also significantly decreased, while Mas mRNA and protein level was increased. Taken together, these studies demonstrated that the expression of ACE2-Ang (1-7) axis was induced in pressure-overload-induced heart failure model, suggesting that ACE2-Ang (1-7) axis may have a protective role in the development of heart failure and may provide a new target for drug development of heart failure.

Entities:  

Keywords:  ACE2; Ang (1-7); pressure-overload-induced heart failure; rat

Mesh:

Substances:

Year:  2015        PMID: 25973029      PMCID: PMC4396342     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction.

Authors:  Yu Xia Zhao; Hui Qiu Yin; Qing Tao Yu; Yun Qiao; Hong Yan Dai; Ming Xiang Zhang; Lei Zhang; Yun Fang Liu; Lai Cheng Wang; De Shan Liu; Bi Ping Deng; Yue Hui Zhang; Chun Ming Pan; Huai Dong Song; Xun Qu; Hong Jiang; Chun Xi Liu; Xiao Ting Lu; Bin Liu; Fei Gao; Bo Dong
Journal:  Hum Gene Ther       Date:  2010-11       Impact factor: 5.695

Review 2.  Angiotensin-(1-7) and the renin-angiotensin system.

Authors:  Robson A S Santos; Anderson J Ferreira
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-03       Impact factor: 2.894

Review 3.  Current perspectives on cardiac function in patients with diastolic heart failure.

Authors:  Jianwen Wang; Sherif F Nagueh
Journal:  Circulation       Date:  2009-03-03       Impact factor: 29.690

Review 4.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Authors:  Puja K Mehta; Kathy K Griendling
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-26       Impact factor: 4.249

5.  Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

Authors:  JiuChang Zhong; Ratnadeep Basu; Danny Guo; Fung L Chow; Simon Byrns; Manfred Schuster; Hans Loibner; Xiu-hua Wang; Josef M Penninger; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Circulation       Date:  2010-08-02       Impact factor: 29.690

6.  Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).

Authors:  Justin L Grobe; Adam P Mecca; Melissa Lingis; Vinayak Shenoy; Tonya A Bolton; Juline M Machado; Robert C Speth; Mohan K Raizada; Michael J Katovich
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-10       Impact factor: 4.733

7.  Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.

Authors:  Gavin Y Oudit; Zamaneh Kassiri; Mikin P Patel; Mark Chappell; Jagdish Butany; Peter H Backx; Robert G Tsushima; James W Scholey; Rama Khokha; Josef M Penninger
Journal:  Cardiovasc Res       Date:  2007-04-21       Impact factor: 10.787

8.  Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.

Authors:  Chantal Mercure; Alvaro Yogi; Glaucia E Callera; Anna B Aranha; Michael Bader; Anderson J Ferreira; Robson A S Santos; Thomas Walther; Rhian M Touyz; Timothy L Reudelhuber
Journal:  Circ Res       Date:  2008-10-09       Impact factor: 17.367

9.  Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure.

Authors:  Masatsugu Ohtsuki; Shin-Ichiro Morimoto; Hideo Izawa; Tevfik F Ismail; Hatsue Ishibashi-Ueda; Yasuchika Kato; Taiko Horii; Tadashi Isomura; Hisayoshi Suma; Masanori Nomura; Hitoshi Hishida; Hiroki Kurahashi; Yukio Ozaki
Journal:  Int J Cardiol       Date:  2010-01-08       Impact factor: 4.164

Review 10.  Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

Authors:  Robson A S Santos; Anderson J Ferreira; Ana Cristina Simões E Silva
Journal:  Exp Physiol       Date:  2008-02-29       Impact factor: 2.969

View more
  9 in total

Review 1.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

2.  Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.

Authors:  Xiaowei Zhang; Heng-Jie Cheng; Peng Zhou; Dalane W Kitzman; Carlos M Ferrario; Wei-Min Li; Che Ping Cheng
Journal:  Int J Cardiol       Date:  2017-01-10       Impact factor: 4.164

Review 3.  Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19.

Authors:  Shreya Sarkar; Rwik Sen
Journal:  Epigenomes       Date:  2022-04-21

4.  The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.

Authors:  Juan Wang; Wen He; Liping Guo; Yin Zhang; Hui Li; Suxia Han; Difei Shen
Journal:  Mol Med Rep       Date:  2017-06-23       Impact factor: 2.952

5.  Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs.

Authors:  Qiaoli Feng; Chengzhi Lu; Li Wang; Lijun Song; Chao Li; Ravi Chandra Uppada
Journal:  BMC Cardiovasc Disord       Date:  2017-02-17       Impact factor: 2.298

6.  Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.

Authors:  Hisashi Kai; Mamiko Kai; Hiroshi Niiyama; Norihito Okina; Motoki Sasaki; Takanobu Maeda; Atsushi Katoh
Journal:  Hypertens Res       Date:  2021-03-10       Impact factor: 3.872

7.  Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model.

Authors:  María Sánchez-Aguilar; Luz Ibarra-Lara; Leonardo Del Valle-Mondragón; Elizabeth Soria-Castro; Juan Carlos Torres-Narváez; Elizabeth Carreón-Torres; Alicia Sánchez-Mendoza; María Esther Rubio-Ruíz
Journal:  PPAR Res       Date:  2020-11-27       Impact factor: 4.964

Review 8.  Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.

Authors:  Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

9.  Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.

Authors:  Hajira Dambha-Miller; Ali Albasri; Sam Hodgson; Christopher R Wilcox; Shareen Khan; Nazrul Islam; Paul Little; Simon J Griffin
Journal:  BMJ Open       Date:  2020-09-14       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.